In this volume supportive care in cancer therapy a part of the cancer drug discovery and development series the contributors provide an up to date concise review of specific consequences of cancer and its treatment the book will assist those who care for the cancer patient to better understand all of the consequences of cancer and its treatment in addition the reader will gain thoughtful information on the care of the older patient as well as the dying patient. Supportive care of the cancer patient begins with the diagnosis of cancer and terminates with the end of life the supportive care is for symptoms related to the cancer and or its treatment physical psychosocial and emotional issues associated with the cancer patients with cancer in general are living longer even those with advanced metastatic disease have an increase in their survival this in part is due to better therapies novel treatments and the multimodality approaches to . Generally drug development is a long process because a potential new drug must be identified and then evaluated in preclinical and clinical studiesthe discovery of a potential new drug can occur . Why publish with us we are published in partnership with the multinational association of supportive care in cancer mascc and are committed to ensuring high visibility for your publication through society membership libraries and social media our journal is ranked 1 in the google scholar h5 index of hospice and palliative care with a 2020 h5 index of 55. Increasing development has led to significant progress in cancer research and therapy in the biopharmaceutical sector drug discovery developments have led in lower death rates among patients suffering from cancer improvements were made in cancer pain management however because of bad evaluation by doctors and the absence of appropriate understanding of new medicines and therapy these improvements have been underutilized the main constraints of the cancer supporting therapy industry are